Last reviewed · How we verify

NCT05849909

Evaluation of the Vulnerable Carotid Atherosclerotic Plaque: A Clinical Multicenter Study

Status unknown Last updated 9 May 2023
What this trial tests

trial in Ultrasound in 57 participants. Status unknown.

Timeline
18 April 2023
Primary endpoint
20 April 2023
18 April 2024

Quick facts

Lead sponsorhuang pintong
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment57
Start date18 April 2023
Primary completion20 April 2023
Estimated completion18 April 2024
Sites1 location across China

Conditions studied

Sponsor

huang pintong

Who can join

Eligibility, any sex, with Ultrasound. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of carotid plaque vulnerability based on ultrasound imaging features, proteomics and metabolomics: a clinical multicenter study

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Ultrasound

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05849909.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing